0 false false false false false false false true false false false false false true false true true No description of principal activity 2024-07-01 Sage Accounts Production Advanced 2025 - FRS102_2025 4 4 4 xbrli:pure xbrli:shares iso4217:GBP OC418224 2024-07-01 2025-06-30 OC418224 2025-06-30 OC418224 2024-06-30 OC418224 2023-07-01 2024-06-30 OC418224 2024-06-30 OC418224 2023-06-30 OC418224 bus:Director1 2024-07-01 2025-06-30 OC418224 core:WithinOneYear 2025-06-30 OC418224 core:WithinOneYear 2024-06-30 OC418224 core:CostValuation core:Non-currentFinancialInstruments 2025-06-30 OC418224 core:Non-currentFinancialInstruments 2025-06-30 OC418224 core:Non-currentFinancialInstruments 2024-06-30 OC418224 bus:SmallEntities 2024-07-01 2025-06-30 OC418224 bus:AuditExemptWithAccountantsReport 2024-07-01 2025-06-30 OC418224 bus:SmallCompaniesRegimeForAccounts 2024-07-01 2025-06-30 OC418224 bus:EntityHasNeverTraded 2024-07-01 2025-06-30 OC418224 bus:LimitedLiabilityPartnershipLLP 2024-07-01 2025-06-30 OC418224 bus:FullAccounts 2024-07-01 2025-06-30
REGISTERED NUMBER: OC418224

The Ridings Medical Group LLP

Filleted Unaudited Financial Statements

For the year ended

30 June 2025

The Ridings Medical Group LLP

Statement of Financial Position

30 June 2025

| 2025 | 2024
Note | £ | £ | £ | £

Fixed assets

Investments | 4 |  | 4 |  | 4

Creditors: amounts falling due within one year | 5 | 4 |  | 4 |
| ---- |  | ---- |
Net current liabilities |  | 4 |  | 4
|  | ---- |  | ----
|  | – |  | –
|  | ---- |  | ----

Represented by:
Loans and other debts due to members

Other amounts |  | – |  | –
|  | ---- |  | ----

Members' other interests

Other reserves |  | – |  | –
|  | ---- |  | ----
|  | – |  | –
|  | ---- |  | ----

Total members' interests

Loans and other debts due to members |  | – |  | –
Members' other interests |  | – |  | –
|  | ---- |  | ----
|  | – |  | –
|  | ---- |  | ----

These financial statements have been prepared and delivered in accordance with the provisions applicable to LLPs subject to the small LLPs' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006 (as applied to LLPs), the statement of comprehensive income has not been delivered.
The LLP did not trade during the current year or prior year and has not made either a profit or loss.
For the year ending 30 June 2025 the LLP was entitled to exemption from audit under section 480 of the Companies Act 2006 (as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008) relating to dormant LLPs.
The members acknowledge their responsibilities for complying with the requirements of the Act (as applied to LLPs) with respect to accounting records and the preparation of financial statements .

The Ridings Medical Group LLP

Statement of Financial Position (continued)

30 June 2025
These financial statements were approved by the members and authorised for issue on 16 December 2025 , and are signed on their behalf by:

Dr R S Horsley
Designated Member

Registered number: OC418224

The Ridings Medical Group LLP

Notes to the Financial Statements

Year ended 30 June 2025

1. | General information

The LLP is registered in England and Wales. The address of the registered office is 4 Centurion Way, Brough, HU15 1AY.

2. | Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland', and the requirements of the Statement of Recommended Practice 'Accounting by Limited Liability Partnerships' issued in December 2021 (SORP 2021).

3. | Accounting policies

(a) Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.
(b) Income statement
The LLP is dormant as defined by section 1169 of the Companies Act 2006 as applied to LLPs by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008. The LLP received no income and incurred no expenditure during the current year or prior year and therefore no income statement is presented within these financial statements. There have been no movements in members funds during the current year or prior year.
(c) Consolidation
The LLP has taken advantage of the option not to prepare consolidated financial statements contained in Section 398 of the Companies Act 2006 as applied to LLPs by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008 on the basis that the LLP and its subsidiary undertakings comprise a small group.
(d) Members' participation rights
Members' participation rights are the rights of a member against the LLP that arise under the members' agreement (for example, in respect of amounts subscribed or otherwise contributed, remuneration and profits).
Members' participation rights in the earnings or assets of the LLP are analysed between those that are, from the LLP's perspective, either a financial liability or equity, in accordance with Section 22 of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland', and the requirements of the Statement of Recommended Practice 'Accounting by Limited Liability Partnerships'. A member's participation right results in a liability unless the right to any payment is discretionary on the part of the LLP.
Amounts subscribed or otherwise contributed by members, for example members' capital, are classed as equity if the LLP has an unconditional right to refuse payment to members. If the LLP does not have such an unconditional right, such amounts are classified as liabilities.
Where profits are automatically divided as they arise, so the LLP does not have an unconditional right to refuse payment, the amounts arising that are due to members are in the nature of liabilities. They are therefore treated as an expense in the statement of comprehensive income in the relevant year. To the extent that they remain unpaid at the year end, they are shown as liabilities in the statement of financial position.
Conversely, where profits are divided only after a decision by the LLP or its representative, so that the LLP has an unconditional right to refuse payment, such profits are classed as an appropriation of equity rather than as an expense. They are therefore shown as a residual amount available for discretionary division among members in the statement of comprehensive income and are equity appropriations in the statement of financial position.
Other amounts applied to members, for example remuneration paid under an employment contract and interest on capital balances, are treated in the same way as all other divisions of profits, as described above, according to whether the LLP has, in each case, an unconditional right to refuse payment.
All amounts due to members that are classified as liabilities are presented in the statement of financial position within 'Loans and other debts due to members' and are charged to the statement of comprehensive income within 'Members' remuneration charged as an expense'. Amounts due to members that are classified as equity are shown in the statement of financial position within 'Members' other interests'.
(e) Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
(f) Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
(g) Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residule interest in the assets of the company after deducting all of its liabilities.

4. | Investments

| Shares in group undertakings
| £
Cost |
At 1 July 2024 and 30 June 2025 | 4
| ----
Impairment |
At 1 July 2024 and 30 June 2025 | –
| ----

Carrying amount |
At 30 June 2025 | 4
| ----
At 30 June 2024 | 4
| ----

5. Creditors: amounts falling due within one year

| 2025 | 2024
| £ | £
Other creditors | 4 | 4
| ---- | ----